Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare

LONDON, March 13, 2014 /PRNewswire/ --

On Wednesday, March 12, 2014, the NASDAQ Composite ended at 4,323.33, up 0.37%, the Dow Jones Industrial Average fell 0.07% to 16,340.08, and the S&P 500 closed at 1,868.20, up 0.03%. The gains were narrow based as four out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 687.90, down 0.01%, while the same has gained 3.36% in the last one month. Investor-Edge.com has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), and ArthroCare Corporation (NASDAQ: ARTC). Free research on these four companies can be accessed at:  

http://investor-edge.com/register

Medtronic Inc.'s stock closed at $59.83 on Wednesday, which is 0.71% lower than the previous day's closing price of $60.26. A total of 4.26 million shares were traded, which is below the three months average volumes of 4.99 million. The company's shares oscillated between $59.64 and $60.24 during the trading session. Medtronic Inc.'s shares have advanced 6.03% in the last one month and 7.51% in the previous three months. The stock is trading at a PE ratio of 16.23 and has gone up 4.25% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. The company's 50-day moving average of $57.86 is above the 200-day moving average of $55.46. Furthermore, the stock is trading at the Relative Strength Index (RSI) of 70.57. Sign up and read the free notes on MDT at:

http://www.Investor-Edge.com/03132014/MDT/report.pdf

Shares in Abbott Laboratories witnessed trading of 6.93 million shares on Wednesday, as compared with a three month average volume of 7.71 million shares. The stock ended the day at $39.66, down 0.13% and at an intraday trading range of $39.44 and $39.89 during the session. The stock traded at a PE ratio of 21.09. Shares in Abbott Laboratories have gained 3.66% in the last one month, 9.29% in the previous three months and 3.47% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. The company's 50-day moving average of $38.44 is above the 200-day moving average of $36.63. Additionally, shares of the company are trading at the Relative Strength Index (RSI) of 60.52. The complimentary notes on ABT can be downloaded as in PDF format at:

http://www.Investor-Edge.com/03132014/ABT/report.pdf

On Wednesday, Hologic Inc.'s stock declined 0.47% finishing the session at $22.11. The stock recorded a trading volume of 2.02 million shares as compared to a three months average volume of 2.62 million shares. The company's shares fluctuated between $21.96 and $22.29 during the session. Hologic Inc.'s shares have advanced 3.27% in the last one month and 2.12% in the previous three months while the same has fallen by 1.07% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. Hologic Inc.'s 50-day moving average of $21.67 is above the 200-day moving average of $21.52. Moreover, shares of the company are trading at the Relative Strength Index (RSI) of 58.73. Register for free on Investor-Edge and access the latest research on HOLX at:

 http://www.Investor-Edge.com/03132014/HOLX/report.pdf

Shares in ArthroCare Corp. recorded a trading volume of 0.30 million shares, as compared with a three month average volume of 0.54 million shares. The stock ended Wednesday's session at $48.15, down 0.06% after vacillating between $48.13 and $48.24. Shares in ArthroCare Corp. have surged 24.13% in the previous three months and 19.66% on YTD basis. The company's shares are trading at a PE ratio of 31.80 and above its 50-day and 200-day moving averages. ArthroCare Corp.'s 50-day moving average of $46.78 is above the 200-day moving average of $38.45. Furthermore, the stock is trading at the Relative Strength Index (RSI) of 55.75. The complete research on ARTC is available for free at:

http://www.Investor-Edge.com/03132014/ARTC/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

=============

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] Investor-edge.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] Investor-edge.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] Investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Investor-Edge.com

SOURCE Investor-Edge

Copyright 2014 PR Newswire